| For: | Ruzzenente A, Valdegamberi A, Campagnaro T, Conci S, Pachera S, Iacono C, Guglielmi A. Hepatocellular carcinoma in cirrhotic patients with portal hypertension: Is liver resection always contraindicated? World J Gastroenterol 2011; 17(46): 5083-5088 [PMID: 22171142 DOI: 10.3748/wjg.v17.i46.5083] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i46/5083.htm |
| Number | Citing Articles |
| 1 |
Nicolas Golse, Petru O. Bucur, René Adam, Denis Castaing, Antonio Sa Cunha, Eric Vibert. New Paradigms in Post-hepatectomy Liver Failure. Journal of Gastrointestinal Surgery 2013; 17(3) doi: 10.1007/s11605-012-2048-6
|
| 2 |
Yun-Hao Tang, Wen-Jiang Zhu, Tian-Fu Wen. Influence of Clinically Significant Portal Hypertension on Hepatectomy for Hepatocellular Carcinoma: a Meta-analysis. Asian Pacific Journal of Cancer Prevention 2014; 15(4) doi: 10.7314/APJCP.2014.15.4.1649
|
| 3 |
Nam Hee Kim, Taeheon Lee, Yong Kyun Cho, Byung Ik Kim, Hong Joo Kim. Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization. Journal of Gastroenterology and Hepatology 2018; 33(7) doi: 10.1111/jgh.14083
|
| 4 |
Yichuan Yuan, Hong Peng, Wei He, Yun Zheng, Jiliang Qiu, Bin Chen, Ruhai Zou, Chenwei Wang, Wan Yee Lau, Binkui Li, Yunfei Yuan. Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial. Cancer Communications 2024; 44(11) doi: 10.1002/cac2.12614
|
| 5 |
Bruno Sangro, Josepmaria Argemi, Maxime Ronot, Valerie Paradis, Tim Meyer, Vincenzo Mazzaferro, Peter Jepsen, Rita Golfieri, Peter Galle, Laura Dawson, Maria Reig. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. Journal of Hepatology 2025; 82(2) doi: 10.1016/j.jhep.2024.08.028
|
| 6 |
Jian-Hong Zhong, Hang Li, Nan Xiao, Xin-Ping Ye, Yang Ke, Yan-Yan Wang, Liang Ma, Jie Chen, Xue-Mei You, Zhi-Yuan Zhang, Shi-Dong Lu, Le-Qun Li, Devanand Sarkar. Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension. PLoS ONE 2014; 9(9) doi: 10.1371/journal.pone.0108755
|
| 7 |
René H Tolba, Uwe Klinge, Christian Bleilevens, Mamdouh Afify, Pramod Kadaba Srinivasan, Avdyl S Krasniqi, Astrit R Hamza. Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection. World Journal of Gastroenterology 2014; 20(40): 14841-14854 doi: 10.3748/wjg.v20.i40.14841
|
| 8 |
Jianwei Liu, Han Zhang, Yong Xia, Tian Yang, Yuzhen Gao, Jun Li, Yeye Wu, Feng Shen. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. HPB 2019; 21(1) doi: 10.1016/j.hpb.2018.07.005
|
| 9 |
Maria C. Russell. Complications Following Hepatectomy. Surgical Oncology Clinics of North America 2015; 24(1) doi: 10.1016/j.soc.2014.09.008
|
| 10 |
Simona Leoni, Fabio Piscaglia, Ilaria Serio, Eleonora Terzi, Irene Pettinari, Luca Croci, Sara Marinelli, Francesca Benevento, Rita Golfieri, Luigi Bolondi. Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group. Digestive and Liver Disease 2014; 46(6) doi: 10.1016/j.dld.2014.02.012
|
| 11 |
Yang Huang, Jiulin Song, Jinli Zheng, Li Jiang, Lunan Yan, Jiayin Yang, Yong Zeng, Hong Wu. Comparison of Hepatic Resection Combined with Intraoperative Radiofrequency Ablation, or Hepatic Resection Alone, for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the University of California San Francisco (UCSF) Criteria: A Propensity Score-Matched Analysis. Annals of Surgical Oncology 2020; 27(7) doi: 10.1245/s10434-020-08231-0
|
| 12 |
Sae Byeol Choi, Hyun Jung Kim, Tae Jin Song, Hyeong Sik Ahn, Sang Yong Choi. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta‐analysis. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(9) doi: 10.1002/jhbp.124
|
| 13 |
Zheng-Liang Chen, Lan-Qing Yao, Jia-Le Pu, Han Wu, Xin-Fei Xu, Ting-Hao Chen, Ya-Hao Zhou, Hong Wang, Zhi-Yu Chen, Li-Yang Sun, Yong-Kang Diao, Jian-Hong Zhong, Wan Yee Lau, Timothy M. Pawlik, Dong-Sheng Huang, Feng Shen, Ying-Jian Liang, Tian Yang. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis. European Journal of Surgical Oncology 2022; 48(5) doi: 10.1016/j.ejso.2021.11.118
|
| 14 |
Ming-Hao Ruan, Fei-Yang Ye, Jin-Ni Ma, Jin Qian, Ming-Hao Zou, Wen-Xuan Zhou, Jie Sheng, Xin-Gang Guo, Dong Wei, Cheng-Jing Zhang, Hui Liu, Fu-Chen Liu. Impact of clinically significant portal hypertension on posthepatectomy liver failure: A systematic review and meta-analysis. World Journal of Hepatology 2026; 18(1): 111871 doi: 10.4254/wjh.v18.i1.111871
Abstract(70) |
Core Tip(50) |
Full Article(HTML)(167)
|
Full Article (PDF)-1032K(47)
|
Full Article with Cover (PDF)-1588K(102)
|
Full Article (XML)-149K(27)
|
Audio-1290K(12)
|
Peer-Review Report-256K(33)
|
Answering Reviewers-105K(35)
|
Supplementary Material-1488K(25)
|
Times Cited (0)
|
Total Visits (423)
|
Open
|
| 15 |
Giuseppina Brancaccio, Alessandro Vitale, Francesco Paolo Russo, Giuseppe Cabibbo, Salvatore Gruttadauria, Duilio Pagano, Giovanni Battista Levi Sandri, Valerio Giannelli, Matteo Cescon, Carlo Sposito, Daniele Nicolini, Leonardo Centonze, Stefano Di Sandro, Davide Ghinolfi, Giovanni Di Costanzo, Raffaella Tortora, Luca Viganò, Fabrizio Romano, Mattia Garancini, Maria Rendina, Francesca Romana Ponziani, Felice Giuliante, Tommaso Manzia, Umberto Baccarani, Riccardo Pravisani, Fabio Melandro, Quirino Lai, Massimo A. Iavarone, Filomena Morisco, Francesco D'Amico, Edoardo Giannini, Giovanni Battista Gaeta, Umberto Cillo. Direct Acting Antivirals Before Surgical Resection of HCV Related HCC: Impact on Tumour Pathology and Outcomes. Liver International 2026; 46(7) doi: 10.1111/liv.70738
|
| 16 |
Xiwen Wu, Hao Chen, Yang Yi, Wen Zhu, Xiaojun Zeng, Yu Wang, Jian Yang, Chihua Fang. Tailored subsegmental resection using augmented reality navigation combined with fluorescence imaging for hepatocellular carcinoma in the right liver: a propensity score-matched cohort study on parenchymal preservation and oncologic outcomes. International Journal of Surgery 2026; doi: 10.1097/JS9.0000000000005275
|
| 17 |
Badawy A. Abdulaziz, Waleed El Agawy, Mohamed El-Tantawy Ibrahim, Medhat A. Khalil, Walid A. Abdel Halim.
Significance of Carbohydrate Antigen 19-9 as a biomarker in Hepatocellular Carcinoma and Cholangiocarcinoma
. The Open Biomarkers Journal 2021; 11(1) doi: 10.2174/1875318302111010039
|
| 18 |
Shilei Bai, Yizhe Dai, Pinghua Yang, Zhengqing Lei, Fuchen Liu, Zhao Yang, Fengwei Li, Yong Xia, Feng Shen, Kui Wang. Development models to predict complication and prognosis following liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension. The American Journal of Surgery 2025; 241 doi: 10.1016/j.amjsurg.2024.116172
|
| 19 |
Ramón Charco, Juan Echeverri, Elena Fernandez de Sevilla, Gonzalo Sapisochin. Management of “very early” hepatocellular carcinoma on cirrhotic patients. World Journal of Hepatology 2014; 6(11): 766-775 doi: 10.4254/wjh.v6.i11.766
|
| 20 |
Jia-Hong Dong, Ke-Sen Xu, Yang Liu, Xiang-Fei Meng, Chong-Hui Li, Guang-Yun Yang, Ying Luo, Wen-Ping Lv, Zhe Liu, Xian-Qiang Wang. Safety validation of decision trees for hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(31): 9394-9402 doi: 10.3748/wjg.v21.i31.9394
|
| 21 |
Qiang-Bo Zhang, Xiu-Guo Zhang, Run-de Jiang, Chun-Xiao Hu, Dong Sun, Lin Ran, Zong-Li Zhang. Microwave ablation versus hepatic resection for the treatment of hepatocellular carcinoma and oesophageal variceal bleeding in cirrhotic patients. International Journal of Hyperthermia 2017; 33(3) doi: 10.1080/02656736.2016.1257824
|
| 22 |
María Sarai González Huezo, Juan Francisco Sánchez Ávila. Consenso mexicano de diagnóstico y manejo del carcinoma hepatocelular. Revista de Gastroenterología de México 2014; 79(4) doi: 10.1016/j.rgmx.2014.09.004
|
| 23 |
Mark Pines. Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. World Journal of Gastroenterology 2014; 20(40): 14778-14786 doi: 10.3748/wjg.v20.i40.14778
|
| 24 |
Wei He, Qingli Zeng, Yun Zheng, Meixian Chen, Jingxian Shen, Jiliang Qiu, Miao Chen, Ruhai Zou, Yadi Liao, Qijiong Li, Xianqiu Wu, Binkui Li, Yunfei Yuan. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1280-3
|
| 25 |
R. Santambrogio, J. Salceda, M. Costa, M.D. Kluger, M. Barabino, A. Laurent, E. Opocher, D. Azoulay, D. Cherqui. External validation of a simplified BCLC staging system for early hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 2013; 39(8) doi: 10.1016/j.ejso.2013.05.001
|
| 26 |
Xiao-Pei Li, Ying Liu, Chun-Qing Zhang. Correlation Between NAT2 Gene Polymorphism and Cirrhotic Portal Hypertension in the Chinese Population. Genetic Testing and Molecular Biomarkers 2015; 19(3) doi: 10.1089/gtmb.2014.0283
|
| 27 |
Ferenc Jakab. Sebészi kockázat májbetegeken. Magyar Sebészet 2013; 66(3) doi: 10.1556/maseb.66.2013.3.1
|
| 28 |
Hazem M. Zakaria, Emad H. Gad, Ali Nada, Anwar A. Abdelaleem, Doha Maher, Mohammad E. Abdel Samea, Alyaa Sabry. Hepatic resection for hepatocellular carcinoma in cirrhotic patients with portal hypertension. Surgical Practice 2016; 20(4) doi: 10.1111/1744-1633.12215
|
| 29 |
Masaaki Hidaka, Susumu Eguchi, Takanobu Hara, Akihiko Soyama, Satomi Okada, Takashi Hamada, Shinichiro Ono, Tomohiko Adachi, Kengo Kanetaka, Mitsuhisa Takatsuki. A Predictive Formula for Portal Venous Pressure Prior to Liver Resection Using Directly Measured Values. Journal of Investigative Surgery 2020; 33(2) doi: 10.1080/08941939.2018.1476631
|
| 30 |
Emil Iskandarov, Pramod Kadaba Srinivasan, Wang Xin, Christian Bleilevens, Mamdouh Afify, Astrit Hamza, Lai Wei, Koichiro Hata, Boyukkishi Agayev, Rene Tolba. Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model. Hepatitis Monthly 2016; 16(8) doi: 10.5812/hepatmon.36821
|
| 31 |
Kosuke Kobayashi, Emilie Uldry, Takashi Kokudo, Alessandra Cristaudi, Yoshikuni Kawaguchi, Chikara Shirata, Takamune Yamaguchi, Olivier Dormond, Rafael Duran, Kiyoshi Hasegawa, Nicolas Demartines, Nermin Halkic. Correlation Between Portal Pressure and Indocyanine Green Retention Rate is Unaffected by the Cause of Cirrhosis: A Prospective Study. World Journal of Surgery 2021; 45(8) doi: 10.1007/s00268-021-06111-6
|
| 32 |
Takashi Kokudo, Kiyoshi Hasegawa, Chikara Shirata, Meguri Tanimoto, Takeaki Ishizawa, Junichi Kaneko, Nobuhisa Akamatsu, Junichi Arita, Nicolas Demartines, Emilie Uldry, Norihiro Kokudo, Nermin Halkic. Assessment of Preoperative Liver Function for Surgical Decision Making in Patients with Hepatocellular Carcinoma. Liver Cancer 2019; 8(6) doi: 10.1159/000501368
|
| 33 |
Shakira Hoque, Christy Kim, Mihir Desai, Pram Sirimana, Malin Katarina Schumacher, Sri Jasti, Mostafa Abasseri, Oliver M.Fisher, Francis Chu, Suhrid Lodh, Natalie Collier, Winston Liauw, Piotr Milkiewicz, Amany Zekry. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; doi: 10.1002/9781119756422.ch18
|
| 34 |
Annalisa Berzigotti, Maria Reig, Juan G. Abraldes, Jaime Bosch, Jordi Bruix. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis. Hepatology 2015; 61(2) doi: 10.1002/hep.27431
|
| 35 |
Tianfu Wen, Chuan Li, Lei Li. Operative Techniques in Liver Resection. 2016; doi: 10.1007/978-94-017-7411-6_3
|
| 36 |
Jian-Hong Zhong, Guido Torzilli, Hao Xing, Chao Li, Jun Han, Lei Liang, Han Zhang, Shu-Yang Dai, Le-Qun Li, Feng Shen, Tian Yang. Controversies and evidence of hepatic resection for hepatocellular carcinoma. BBA Clinical 2016; 6 doi: 10.1016/j.bbacli.2016.10.001
|
| 37 |
Roberto Santambrogio, Michael D. Kluger, Mara Costa, Andrea Belli, Matteo Barabino, Alexis Laurent, Enrico Opocher, Daniel Azoulay, Daniel Cherqui. Hepatic resection for hepatocellular carcinoma in patients with Child–Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?. HPB 2013; 15(1) doi: 10.1111/j.1477-2574.2012.00594.x
|
| 38 |
María Reig, Annalisa Berzigotti, Jordi Bruix. If portal hypertension predicts outcome in cirrhosis, why should this not be the case after surgical resection?. Liver International 2013; 33(10) doi: 10.1111/liv.12273
|
| 39 |
D. Bettinger, E. Knüppel, W. Euringer, H. C. Spangenberg, M. Rössle, R. Thimme, M. Schultheiß. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2015; 41(1) doi: 10.1111/apt.12994
|
| 40 |
María Sarai González Huezo, Juan Francisco Sánchez Ávila. Mexican consensus on the diagnosis and management of hepatocellular carcinoma. Revista de Gastroenterología de México (English Edition) 2014; 79(4) doi: 10.1016/j.rgmxen.2014.12.002
|